Conversely, in a recent study, increased expression of Igfbp5 was detected in skeletal muscle biopsies of spinal muscular atrophy (SMA) patients and non-SMA neuromuscular diseases (92). This evidence concerns the gene IGFBP5 and neuromuscular disease.